Abstract
Biomarkers are necessary for screening and diagnosing numerous diseases, predicting the prognosis of patients, and following-up treatment and the course of the patient. Everyday new biomarkers are being used in clinics for these purposes. This section will discuss the physiological roles of the various current biomarkers in a healthy person and the pathophysiological mechanisms underlying the release of these biomarkers. This chapter aims to gain a new perspective for evaluating and interpreting the most current biomarkers.
Keywords: AFP, Alpha-fetoprotein, CA15-3, CA27.29, Carcinoembryonic antigen, CEA, GFAP, GPBB, GSTP-1, H-FABP, MUC1, NSE, NT-proBNP, Pathophysiological mechanisms, Physiology, S100B, Troponin.
Related Journals
Current Surgical Endoscopy
Current Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine
Current Signal Transduction Therapy
Drug Metabolism and Bioanalysis Letters
Recent Patents on Biotechnology
Current Molecular Medicine
Current Genomics
Current Pharmaceutical Biotechnology
Current Proteomics
Related Books
Bioluminescent Marine Plankton
Sustainable Utilization of Fungi in Agriculture and Industry
Myconanotechnology: Green Chemistry for Sustainable Development
Industrial Applications of Soil Microbes
Industrial Applications of Soil Microbes
Industrial Applications of Soil Microbes
Environmental Microbiology: Advanced Research and Multidisciplinary Applications
Biopolymers Towards Green and Sustainable Development
Algal Biotechnology for Fuel Applications
New Trends In Biomarkers and Diseases Research: An Overview